Myasthenia gravis Flashcards
———— and ———are cholinesterase inhibitors that are used to treat myasthenia gravis.
Neostigmine and pyridostigmine are cholinesterase inhibitors that are used to treat myasthenia gravis.
Myasthenia gravis is a type —– hypersensitivity disorder where autoantibodies target ——- receptors.
Myasthenia gravis is a type II hypersensitivity disorder where autoantibodies target nicotinic acetylcholine receptors.
Neostigmine is used to (treat/diagnose) ——-myasthenia gravis.
Neostigmine is used to (treat/diagnose) treat myasthenia gravis.
Myasthenia gravis symptoms generally starts with weakness of the ——-muscles.
Myasthenia gravis symptoms generally starts with weakness of the ocular muscles.
Acetylcholinesterase inhibitors (improve/worsen) ——- the symptoms of myasthenia gravis.
Acetylcholinesterase inhibitors (improve/worsen) improve the symptoms of myasthenia gravis.
——– is an acetylcholinesterase inhibitor drug that was historically used to diagnose myasthenia gravis.
Edrophonium is an acetylcholinesterase inhibitor drug that was historically used to diagnose myasthenia gravis.
Edrophonium is a(n) (drug class) ——-inhibitor drug used for the diagnosis of myasthenia gravis.
Edrophonium is a(n) (drug class) acetylcholinesterase inhibitor drug used for the diagnosis of myasthenia gravis.
The classical clinical presentation of a patient with myasthenia gravis is a patient with (eye symptoms) —-and muscle weakness that worsens with —-.
The classical clinical presentation of a patient with myasthenia gravis is a patient with (eye symptoms) ptosis, diplopia and muscle weakness that worsens with use.
(Females/Males) ——are more affected by myasthenia gravis.
(Females/Males) Females are more affected by myasthenia gravis.
Myasthenia gravis is a neuromuscular junction disorder that is associated with malignancies like ——–
Myasthenia gravis is a neuromuscular junction disorder that is associated with malignancies like bronchogenic carcinoma or thymic neoplasm.
——–is the most common neuromuscular junction disorder.
Myasthenia gravis is the most common neuromuscular junction disorder.